A Study of FL115 in Combination With a PD-1 Antibody in Advanced Solid Tumors
Clinical trial NCT07131202 · RECRUITING
Trial details
- NCT number
- NCT07131202
- Sponsor
- Suzhou Forlong Biotechnology Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-08
- Primary completion
- 2026-12-05
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.